BILL NUMBER: SB 471	AMENDED
	BILL TEXT

	AMENDED IN SENATE  MAY 28, 2009
	AMENDED IN SENATE  MAY 6, 2009
	AMENDED IN SENATE  APRIL 22, 2009
	AMENDED IN SENATE  APRIL 2, 2009

INTRODUCED BY   Senators Romero and Steinberg
   (Coauthor: Senator Alquist)

                        FEBRUARY 26, 2009

   An act to add Article 13 (commencing with Section 33475) to
Chapter 3 of Part 20 of Division 2 of Title 2 of the Education Code,
relating to education.



	LEGISLATIVE COUNSEL'S DIGEST


   SB 471, as amended, Romero. California Stem Cell and Biotechnology
Education and Workforce Development Act.
   The California Stem Cell Research and Cures Act, an initiative
measure approved by the voters at the November 2, 2004, general
election (Proposition 71), establishes the California Institute for
Regenerative Medicine (CIRM), the purpose of which is, among other
things, to make grants and loans for stem cell research, for research
facilities, and for other vital research opportunities to realize
therapies, protocols, and medical procedures that will result in the
cure for, or substantial mitigation of, diseases and injuries.
   This bill would create the California Stem Cell and Biotechnology
Education and Workforce Development Act of 2009 to establish stem
cell and biotechnology education and workforce development as a state
priority and to promote  a stronger link  
stronger links  among industry sectors, the CIRM, and California
public schools. This bill would require the State Department of
Education, in consultation with the CIRM and representatives of the
biotechnology industry, to promote stem cell and biotechnology
education and workforce development in the department's existing
programs, as specified.
   The bill would also require the  state board 
 State Board of Education  to incorporate stem cell science
curriculum content into  the  science curriculum framework
at its next  science curriculum  revision. The bill
would request that the Regents of the University of California
consult with the CIRM and representatives of the biotechnology
industry in developing curriculum for the California State Summer
School for Mathematics and Science.  The bill, on and after
January 1, 2011, would require the science subject matter project,
upon agreement by the Regents of the University of California, in
consultation with the CIRM and representatives of the biotechnology
industry, to pursue opportunities to include stem cell and
biotechnology science in professional development programs. 

   Vote: majority. Appropriation: no. Fiscal committee: yes.
State-mandated local program: no.


THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS:

  SECTION 1.  The Legislature finds and declares all of the
following:
   (a) If California is to retain its premier position in stem cell
research and fully realize the medical and economic benefits of
regenerative medicine,  a stronger link is  
stronger links are  needed between California public schools and
this emerging industry.
   (b) At the November 2004 statewide general election, California
voters approved Proposition 71, the California Stem Cell Research and
Cures Initiative, which authorizes $3 billion in state bond funding
for stem cell research at California universities and research
institutions and added Article XXXV to the California Constitution
and Sections 125290.10 et seq. to the Health and Safety Code.
   (c) Proposition 71 established a new state agency, the California
Institute for Regenerative Medicine (CIRM), to make grants and
provide loans for stem cell research and research facilities.
   (d) The ballot pamphlet information and findings and declarations
of Proposition 71 described how stem cell research will lead to the
development of life-saving regenerative treatments and cures for a
variety of incurable diseases, including cancer, diabetes, heart
disease, Alzheimer's disease, Parkinson's disease, spinal cord
injuries, multiple sclerosis, and Huntington's disease; and also
benefit the California economy by creating projects, jobs, and
therapies that will generate millions of dollars in new tax revenues
in our state and advance the biotech industry in California to world
leadership as an economic engine for California's future.
   (e) The public funding of stem cell research, combined with
significant private donations, has made California the national
leader in stem cell research.
   (f) After President Bush limited federal funding for embryonic
stem cell research in 2001, most states eliminated or significantly
reduced stem cell research.
   (g) On March 9, 2009, President Obama issued an executive order
lifting restrictions on federal funding for stem cell research,
leading other states to move quickly to try to catch up to
California.
   (h) Several recent reports have predicted that California will
soon face a dramatic shortage of trained professionals to fill jobs
in the life sciences sector and a more widespread shortage of college
educated and technically trained workers to meet industry demands.
   (i) California's growing gap between supply and demand for
 college educated   college-educated  and
technically trained workers is exacerbated by an alarming high school
dropout rate.
   (j) Education must be the cornerstone of California's economic
development strategy, and education that is closely linked to the
needs of emerging industries is critical. 
   (k) CIRM, in recognition that the rapid progress in stem cell
research in California will lead to the development of treatments and
cures, to the growth of regenerative medicine and the stem cell
industry, and 
    (k)     The CIRM, in recognition that
translating stem cell research into therapies and cures  will
require an expanding pool of individuals with specialized training
and skills, has  tentatively  made Bridges to Stem
Cell Research grants to fund research and training activities for
postsecondary students interested in careers in regenerative
medicine.
   (l)  The  CIRM also is developing a "California Stem Cell
Education Initiative" aimed at high schools with the goal of broadly
educating California pupils about stem cell science and regenerative
medicine and creating pathways for careers in the stem cell
industry.
   (m) The biotechnology industry, in response to an ongoing shortage
of appropriately educated and trained graduates to meet its
workforce requirements, has invested tens of millions of dollars
developing and implementing science and math education programs in
California.  The California Biotechnology Foundation
  An industry group is releasing a comprehensive
directory of these  industry  programs as a resource
for other schools to implement similar programs.
   (n) In order to ensure that all California pupils have an
opportunity for a career in the stem cell and biotechnology
industries and that California fully  realize  
realizes  the medical and economic benefits these industries
offer, including the benefits made possible by the substantial public
investment California has made in stem cell research and facilities,
all education policymakers and institutions of public education, and
all relevant public agencies and industry organizations, should
collaborate and make it a priority to increase stem cell and
biotechnology education and workforce development.
  SEC. 2.  Article 13 (commencing with Section 33475) is added to
Chapter 3 of Part 20 of Division 2 of Title 2 of the Education Code,
to read:

      Article 13.  The California Stem Cell and Biotechnology
Education  and  Workforce Development Act of 2009


   33475.  This article shall be known, and may be cited, as the
California Stem Cell and Biotechnology Education and Workforce
Development Act of 2009.
   33475.1.  The purpose of this article is to establish stem cell
and biotechnology education and workforce development as a state
priority and to promote  a stronger link  
stronger links  among these industry sectors, the California
Institute for Regenerative Medicine, and California public schools.
   33475.2.  For purposes of this article, the following definitions
shall apply:
   (a) "CIRM" means the California Institute for Regenerative
Medicine.
   (b) "Department" means the State Department of Education.
   33475.3.  The department, in consultation with  the  CIRM
and representatives of the biotechnology industry, shall promote
stem cell and biotechnology education and workforce development in
the department's existing programs, including, but not limited to,
all of the following:
   (a) The California Health Science Educators Institute.
   (b) The Health Science Capacity Building Project.
   (c) The California Partnership Academies  , pursuant to
Article 5 (commencing with   Section 54690) of Chapter 9 of
Part 29 of Division 4  .
   (d) The regional science resource centers, pursuant to Chapter 3.6
(commencing with Section 44770) of Part 25 of Division 3.
   (e) The California  Career  Resource Network, including
the State Agency Partners Committee.
   (f) Multiple pathway programs pursuant to Section 52372.5.
   (g) The K-12 High Speed Network, pursuant to Section 11800,
including its academic content platform.
   33475.4.  The department shall post on its Internet Web site
information and links to information about the following:
   (a)  Existing biotechnology   Biotechnology
 education programs, including, but not limited to, those
identified by the  California Biotechnology Foundation.
  biotech industry and industry-related organizations.

   (b)  The    CIRM education initiatives and
related stem cell education and workforce development programs.
   33475.5.  The state board shall incorporate stem cell science
curriculum content into  th   e  science curriculum
framework at its next  science curriculum 
revision.
   33475.6.  The Regents of the University of California are
requested to consult with the CIRM and  representative
  representatives  of the biotechnology industry in
developing curriculum for the California State Summer School for
Mathematics and Science pursuant to Chapter 3.8 (commencing with
Section 8660) of Part 6 of Division 1 of Title 1. 
   33475.7.   Commencing January 1, 2011, the science subject matter
project described in Section 99201, upon agreement by the Regents of
the University of California, in consultation with the CIRM and
representatives of the biotechnology industry, shall include stem
cell and biotechnology science in professional development programs.

    33475.8.   33475.7.   It is requested
that the Independent Citizens Oversight Committee  of CIRM
 , when allocating funds for stem cell research and
facilities pursuant to Chapter 3 (commencing with Section 125290.10)
of Part 5 of Division 106 of the Health and Safety Code, consider
education and workforce development in addition to other criteria,
with the goal of furthering the purpose of this article.